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Abstract 35 
 36 
Objective: Septic arthritis results from joint infection by Staphylococcus aureus which produces potent alpha 37 
(α)-toxin causing cell death, potentially leading to permanent cartilage damage. Treatment is by joint irrigation 38 
and antibiotics, although it is unclear if, following treatment with antibiotics which cause bacterial lysis, there 39 
is release of additional stored (α)-toxin.  40 
Design: A rabbit erythrocyte haemolysis assay was optimised to assess biologically-active α-toxin from 41 
cultured S. aureus (α)-toxin strain DU5946. Haemoglobin release was measured spectrophotometrically 42 
following addition of a bacteriostatic/bactericidal antibiotic (linezolid) or a bacteriolytic antibiotic (penicillin). 43 
A bovine cartilage model of septic arthritis was utilised to test the protective effects of antibiotics against S. 44 
aureus infection. 45 
Results: During S. aureus culture, α-toxin levels increased rapidly but the rate of rise was quickly (within 46 
20mins) suppressed by linezolid (25μg/ml). Penicillin also reduced the increase in α-toxin levels, however the 47 
time course was relatively slow compared to linezolid even at high concentrations (50,000U/ml). The efficacy 48 
of penicillin (250,000U/ml) at reducing the rise in α-toxin was approximately 8% less than that of linezolid 49 
(P<0.05) suggesting the presence of additional toxin. This could be due to a delayed action of penicillin, and/or 50 
release of a small pool of stored α-toxin from dying bacteria. In a bovine cartilage model however, there was 51 
no difference between the protection of in situ chondrocytes against S. aureus by penicillin or linezolid 52 
(P>0.05). 53 
Conclusion: The results suggested that equally effective protection of chondrocytes against S. aureus septic 54 
arthritis may be obtained by the bacteriostatic/bactericidal or bacteriolytic antibiotics tested.  55 
 56 
 57 
Key words: Staphylococcus aureus; bacteriostatic; bactericidal; antibiotic; α-toxin; septic arthritis. 58 
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Introduction 61 
 62 
Septic arthritis, resulting from joint inflammation secondary to infection1, can be highly destructive 63 
leading to cartilage damage and joint failure2-4. It affects all ages with an incidence in Western Europe of 4-10 64 
cases/100,000 persons/yr5. The incidence of septic arthritis is rising globally due to various factors including 65 
an ageing population, increased use of immunosuppressive agents, musculoskeletal prosthesis and surgical 66 
procedures5-7. Although numerous bacterial species may induce septic arthritis, Staphylococcus aureus 67 
accounts for 40-60% of cases2,3,8 with invasive healthcare-associated methicillin-resistant S. aureus (MRSA) 68 
infections accounting for 18 per 100,000 persons/yr9. The bacteria enter the synovial joint mainly by 69 
haematogenous spread5, and the infection results in chondrocyte death, leading to cartilage degeneration and 70 
tissue erosion2,3. Chondrocyte death is particularly important as these are the only cell type capable of 71 
maintaining cartilage resilience through their regulation of extracellular matrix metabolism10. Septic arthritis 72 
can lead to osteoarthritis (OA11) which contributes to the high morbidity associated with the disease, and may 73 
also lead to fatal septicaemia7.  74 
S. aureus produces an array of potential virulence factors (e.g. toxins, adhesins), which contribute to 75 
colonisation and subsequent tissue destruction. The toxins may damage host cells directly or facilitate evasion 76 
of the host immune response12. Depending on the strain, S. aureus may release toxins including α, β, and γ-77 
toxins in addition to damaging agents including Panton-Valentine leucocidin (PVL) and super-antigens (e.g. 78 
toxic shock syndrome toxin)13. A bovine cartilage explant model of S. aureus-induced septic arthritis, however 79 
reported that the ‘pore forming’ alpha (α)-toxin is the key damaging agent causing rapid chondrocyte death 80 
whereas the β and γ-toxins were relatively ineffectual14,15. Alpha-toxin is active against a variety of mammalian 81 
cells, but has marked potency against rabbit red blood cells (RBCs) via the ADAM-10 receptor which is also 82 
present on human chondrocytes16-18. Rabbit RBCs haemolysis can be quantified spectrophotometrically and 83 
thus is a very useful and sensitive biological assay for S. aureus α-toxin19,20. 84 
Treatment for septic arthritis includes intravenous antibiotics with joint lavage1, however retrospective 85 
studies indicate that some permanent cartilage damage develops in ~50% of cases2-4, thus its rapid and effective 86 
treatment is essential. When patients present, the joint is aspirated to obtain a microbiological profile of the 87 
synovial fluid. As identification of the causative micro-organism may take ~48hrs, patients are traditionally 88 
empirically commenced on intravenous antibiotics with joint lavage.  Beta (β) lactam type antibiotics such as 89 
benzyl penicillin (penicillin-G) and flucloxacillin are classed as bacteriolytic as they kill the bacteria through 90 
damage to the cell wall21,22. However, this may release cellular contents including S. aureus α-toxin potentially 91 
causing additional chondrocyte death above that occurring when the bacteria were alive. In contrast, antibiotics 92 
such as linezolid and erythromycin are bacteriostatic at low concentrations by inhibiting bacterial growth and 93 
replication, which may then be followed by their removal by the immune system23,24, whereas at higher levels 94 
they are bactericidal24,25. Thus these agents can be described as bacteriostatic/bactericidal. The choice of 95 
antibiotic for S. aureus septic arthritis treatment is important as it could influence the amount of α-toxin in the 96 
synovial space, chondrocyte death and subsequent cartilage damage.  97 
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Here, we have utilised two isogenic mutants (DU5946, DU5938) from the well-characterised 98 
prophage-cured derivative of NCTC8325 S. aureus 8325-426. NCTC8325 was originally isolated from a patient 99 
with joint sepsis and its lineage remains a valuable resource for S. aureus research27. These mutants produce 100 
the range of toxins26,28,29 and the mutations only affect the synthesis of alpha-haemolysin (α)-toxin) (Hla::Emr), 101 
beta (β)-haemolysin (Hlb::φ42E) and gamma (γ)-haemolysin (Δhlg::Tcr). Thus, while both strains produce 102 
damaging agents, the mutant strain DU5946 only produces α-toxin and not β or γ-haemolysin, whereas the 103 
DU5938 mutant does not produce α, β, or γ-toxins. Levels of biologically active α-toxin during S. aureus 104 
culture, were assessed semi-quantitatively using the sensitive rabbit haemolysis assay19,20. Using this 105 
technique, we tested the hypothesis that α-toxin levels in the culture medium would be higher after the addition 106 
of high concentrations of a bacteriolytic antibiotic (penicillin G) compared to a bacteriostatic/bactericidal 107 
antibiotic (linezolid). The results demonstrated that there was only a small (<10%) further increase in α-toxin 108 
levels from S. aureus cultures following penicillin treatment compared to linezolid. We then tested these two 109 
antibiotics (in addition to two other antibiotics, flucloxacillin (bacteriolytic) and erythromycin 110 
(bacteriostatic/bactericidal)) for their ability to protect articular chondrocytes in a bovine cartilage model of 111 
septic arthritis. The results suggested that both penicillin and linezolid (as well as flucloxacillin and 112 
erythromycin) protected chondrocytes with equal efficacy suggesting that there was a negligible intracellular 113 
α-toxin released from S. aureus following antibiotic treatment.  114 
115 
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Materials and Methods 116 
 117 
(a): Bacterial strains and reagents. Two isogenic mutants of S. aureus 8325-4 (DU5946, DU5938) containing 118 
mutations affecting the synthesis of alpha-haemolysin (α)-toxin (Hla::Emr), beta-haemolysin (Hlb::φ42E) and 119 
gamma haemolysin (Δhlg::Tcr;Table 1) were used. The DU5946 strain produced α-toxin whereas this was not 120 
produced by the DU5938 strain, otherwise the strains were identical. Antibiotics were from Sigma-Aldrich, 121 
Irvine, UK. Fresh, filter-sterilised stock solutions of linezolid (PZ0014), Na-flucloxacillin (F0150000) and 122 
penicillin G (P3032;1477U/mg) were prepared in dH2O whereas erythromycin (E6376) was dissolved in 123 
ethanol-water (6mg/ml).  124 
(b):  Preparation of bacterial pellets, supernatant samples and antibiotics. Bacteria were stored at -80°C in 125 
10%v/w skimmed milk (Oxoid, Basingstoke, UK). When required, they were thawed and streaked onto 126 
tryptone soya agar (TSA;Oxoid) plates containing 2µg/ml tetracycline (Cat. 87128; Sigma-Aldrich). Following 127 
incubation (24hrs;37°C), tryptone soya broth (TSB;Oxoid), containing 2µg/ml tetracycline, was inoculated 128 
with several single bacterial colonies from the TSA plate and incubated (24hr;37°C) with shaking. From this 129 
TSB culture, serial dilutions were performed in saline to 10-6, in order to calculate the number of colony 130 
forming units (CFU). A CFU is defined as a unit used to estimate the number of viable bacteria capable of 131 
reproducing to form a colony of the same bacterial species – the number of CFUs is therefore a measure of the 132 
number of active bacteria in 1ml of TSB cultured for 24hr. Thereafter, 100µl of 10-4, 10-5 and 10-6 dilutions 133 
were spread evenly onto TSA plates and incubated (37°C;24hr). Colonies were then counted using a colony 134 
counter (Stuart®, Bibby Scientific, Stone, UK). Bacterial counts were performed on several cultures for each 135 
strain and a count of ~1x109 CFU/ml (range 0.8-1.25x109 CFU/ml) was routinely obtained. Cultures were then 136 
centrifuged (2,000xg;15min) and the pellets resuspended by vortexing, washing in HBSS and centrifugation 137 
(x3). The supernatant was then removed and the pellets air-dried before being stored (-20oC) and used within 138 
one week. Based on the colony counts, a bacterial pellet contained ~1x105 CFU and the bacteria were used in 139 
the experiments described here at ~0.2x105 CFU in HBSS. TSA plates were prepared to assess effective doses 140 
of antibiotics against S. aureus whose viability was assessed by counting colonies plated on TSA in the 141 
presence/absence of antibiotics following incubation overnight at 37°C. For penicillin and linezolid, doses of 142 
1000U/ml and 25µg/ml respectively were sufficient. For flucloxacillin and erythromycin, doses of 2mg/ml and 143 
10µg/ml respectively were adequate and no viable bacteria were detected. For some experiments where α-144 
toxin levels were assessed by the haemolysis method, higher doses of penicillin (to 250,000U/ml) were used. 145 
Table 2 summarises the antibiotics used with doses, together with sites of action and references. All doses used 146 
were substantially greater than the MIC (minimum inhibitory concentration) in the literature (Table 2).  147 
(c): Rabbit erythrocyte haemolysis assay for α-toxin. The rabbit red blood cell (RBC) haemolysis assay was 148 
used to determine biologically-relevant levels of α-toxin released during S. aureus culture19,20. Fresh, 149 
heparinised RBCs (Orygen, Penicuik, UK), were prepared at ~5% haematocrit in Hank’s balanced salt solution 150 
(HBSS;pH 7.4;Invitrogen, Paisley, UK).  At time zero and at specific points throughout the culture of S. aureus 151 
(see Figures), aliquots were taken and centrifuged (8,000xg;30secs) and the supernatant aliquotted into 152 
microcentrifuge tubes, taking care not to disturb the pellet. The supernatants which contained α-toxin, were 153 
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then added to microcentrifuge tubes containing 5% RBC suspensions, mixed gently and incubated 154 
(37°C;60mins). The samples were then centrifuged (8,000xg;10secs) and the supernatant assessed for 155 
haemoglobin at 540nm (Abs540) on a Nanodrop spectrophotometer (ThermoFisher Scientific, Waltham, USA). 156 
Percent haemolysis (%H) was then calculated ((Abs540 of sample – Abs540 of negative control)/(Abs540 of 100% 157 
haemolysis – Abs540 of negative control) x100%). The sensitivity of RBC samples to α-toxin and the amount 158 
of α-toxin produced from each culture were variable. It was important to minimise this at the beginning of an 159 
experimental week, by initially testing erythrocytes from several rabbits on a freshly-prepared batch of α-toxin. 160 
Erythrocytes which were relatively insensitive to α-toxin requiring >1hr of incubation before haemolysis was 161 
detectable, were not studied further and this reduced the variation in results obtained.   162 
 (d): Assessment of in situ chondrocyte viability by confocal scanning laser microscopy (CLSM). Fresh, healthy 163 
(non-degenerate) metacarpophalangeal joints of 3-yr old cows from a local abattoir, were washed, skinned, 164 
de-hoofed and opened under aseptic conditions. Cartilage explants were cultured in Dulbecco’s Modified 165 
Eagle’s medium (DMEM;pH 7.4;37°C; Invitrogen) in the presence or absence of S. aureus and after 15hrs the 166 
bacteria had caused measurable (~20%) chondrocyte death.  Explants were then exposed to antibiotics (or 167 
control medium) and the incubation continued for up to 23hrs. At the time points indicated, explants were 168 
removed, rinsed in DMEM and chondrocyte viability assessed as described30. Explants were incubated with 5-169 
chloromethylfluorescein diacetate (CMFDA) and propidium iodide (PI;both at 10µM from Invitrogen, Paisley, 170 
UK) in DMEM (1hr;21°C). These probes labelled living or dead cells green or red, respectively. Explants were 171 
then fixed (4% formaldehyde;4hrs;Fisher Scientific, Loughborough, UK), rinsed and stored in PBS, until 172 
imaged within 24hrs. Imaging of fluorescently-labelled in situ chondrocytes was performed as described14,30. 173 
An upright Zeiss LSM510 Axioskop (Carl Zeiss, Welwyn Garden City, UK) CLSM with a x10 (0.3NA) dry 174 
objective was used to acquire axial images. The percentage cell death ((number of dead cells/total number of 175 
living and dead cells) x100%) was calculated within a standard region of interest (ROI) using VolocityTM 4 176 
software (Improvision, Coventry, UK). Within each ROI, individual cells, in both green (living) and red (dead) 177 
channels, were quantified based on percentage voxel (volumetric pixel) intensity14. 178 
(e): Data analysis and statistics. Data are shown as means ± standard error of the mean (S.E.M) from at least 179 
3 independent experiments, and were analysed using GraphPad Prism Ver.6 (GraphPad, San Diego, CA, USA). 180 
Non-parametric t-tests (Kruskal-Wallis) and ANOVAs were performed and significant differences accepted 181 
when P<0.05. 182 
  183 
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Results 184 
 185 
 186 
(a)  S. aureus α-toxin mediated rabbit RBC haemolysis. The strain of S. aureus (DU5946) that harboured the 187 
α-toxin (hla) gene was haemolytic on rabbit blood agar whereas the strain deficient in this gene (DU5938) was 188 
non-haemolytic (Fig. 1(a)). Supernatants were prepared from cultures of these strains and added to suspensions 189 
of rabbit erythrocytes in HBSS. There was a rapid increase in %H for the α-toxin-positive strain, however the 190 
α-toxin-deficient strain had no detectable effect (Fig. 1(b)). Thus, by using rabbit erythrocytes in suspension 191 
as a model and determining haemoglobin release spectrophotometrically, biologically active α-toxin could be 192 
quickly assessed semi-quantitatively.  193 
(b) Time course of linezolid action. Single doses of linezolid (to concentrations of 5-50μg/ml) were added to 194 
the -positive S. aureus cultures (DU5946) at a point corresponding to ~50% haemolysis (after 80mins) and 195 
samples analysed for -toxin-induced haemolysis (Fig. 2(a)). For all concentrations, there was a rapid 196 
reduction in the rate of rise of -toxin-induced haemolysis, and at 25 and 50μg/ml, there was no significant 197 
change in %H (Fig. 2(b)). Addition of linezolid to 50μg/ml at 80, 100, 130mins time points, rapidly suppressed 198 
any further increase in -toxin-induced haemolysis (Fig. 2(c)). Linezolid (50μg/ml) addition  60mins after the 199 
commencement of the S. aureus culture, abolished subsequent -toxin-induced haemolysis compared to the 200 
untreated (infected) control (Fig. 3(a)). The same concentration of linezolid added after 100mins when there 201 
was ~40% haemolysis, also completely inhibited subsequent -toxin-induced haemolysis to the same level 202 
after 40 and 60mins as that present at the start of the experiment (P<0.001; Fig. 3(b)). These results indicated 203 
that the linezolid addition to S. aureus cultures rapidly (within ~20 mins) inhibited -toxin-induced haemolysis 204 
and that 25 and 50μg/ml prevented any further rise.  205 
(c) Time course of penicillin action. Single doses of penicillin G (to 5000, 10,000, 25,000 or 50,000U/ml) were 206 
added to the -toxin positive S. aureus cultures at a time point corresponding to ~50% haemolysis (after 207 
60mins) and samples analysed for -toxin-induced haemolysis (Fig. 4(a)). While at penicillin concentrations 208 
of 50,000U/ml and 250,000U/ml at 140 mins there was a significant reduction in the rate of rise of -toxin-209 
induced haemolysis, the effect of lower concentrations was not significant (Fig. 4(b)). Addition of penicillin 210 
to 50,000U/ml at different time points, suppressed the increase in -toxin-induced haemolysis (Fig. 4(c)), 211 
however the time course of action was slower compared to linezolid (Fig. 2(c)). Penicillin addition 20mins 212 
after the start of the culture, significantly inhibited haemolysis compared to the untreated (infected) control 213 
after 40 and 60mins (Fig. 5(a)). While in the presence of penicillin, there were significant increases in 214 
haemolysis at 40 and 60mins compared to the values at the time of drug addition (P<0.05), these were not 215 
different (P=0.12), indicating a plateau in -toxin levels. When the same concentration of penicillin was added 216 
after 60mins, there was ~60% haemolysis at time zero and this significantly (P<0.001) inhibited subsequent 217 
-toxin-induced haemolysis after 40 and 60mins (Fig. 5(b)). The extent of -toxin-induced haemolysis at 218 
60mins was significantly (P=0.05) higher than the time zero point but not significantly different compared to 219 
the 40min time point (Fig. 5(b)). These results suggested that penicillin addition to S. aureus cultures 220 
progressively reduced the rate of increase of -toxin-induced haemolysis. However, the time course appeared 221 
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relatively slow compared to linezolid, and at the highest concentrations studied (50,000U/ml) there was still a 222 
slight rise in -toxin-induced haemolysis until the inhibition appeared complete.  223 
 To directly compare the inhibitory effects of linezolid and penicillin using the same blood samples and 224 
S. aureus cultures, DU5946 cultures were incubated for 60mins, and then untreated (control) or dosed with 225 
penicillin (250,000U/ml) or linezolid (25μg/ml), and the medium analysed for -toxin for up to 80mins (Fig. 226 
6). After 20mins, both antibiotics significantly (P<0.05) inhibited haemolysis, however at 40, 60 and 80mins 227 
after antibiotic addition, the inhibition was significantly (by ~8%) greater (P<0.05) in the presence of linezolid 228 
(Fig. 6).  The inhibition by penicillin did not change significantly compared to linezolid over the 40-80mins 229 
period after antibiotic addition, suggesting that the inhibitory effect of penicillin was maximal.  230 
(d) Chondrocyte protection in a bovine cartilage septic arthritis model by antibiotics. S. aureus DU5946 was 231 
cultured with cartilage explants and in control (no antibiotics) samples, there was almost complete (>90%) 232 
chondrocyte death after ~21hrs (Fig. 7(a,b)). In contrast, when infected cartilage was treated with penicillin or 233 
linezolid after 15hrs, there was no subsequent chondrocyte death and no difference between the potency of the 234 
two drugs (Fig. 7(a,b)). Similar experiments were performed with flucloxacillin and erythromycin (data not 235 
shown). In the untreated infected samples, there was complete (~100%) chondrocyte death after ~24hrs. 236 
Treatment of infected cartilage samples with flucloxacillin (2mg/ml) or erythromycin (10μg/ml) after 18hrs, 237 
prevented any subsequent chondrocyte death and there was no significant difference (P>0.05) between the two 238 
drugs at any time point studied up to 26hrs after antibiotic addition. Levels of chondrocyte death in the control 239 
(i.e. uninfected and untreated) cartilage samples were <2%. These results suggested that both bacteriolytic 240 
(penicillin, flucloxacillin) and bacteriostatic/bactericidal (linezolid, erythromycin) antibiotics were equally 241 
effective at protecting chondrocytes in the bovine cartilage model of S. aureus septic arthritis.  242 
  243 
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Discussion 244 
 245 
The rabbit erythrocyte haemolysis assay determined the time course of biologically-relevant α-toxin 246 
produced during culture of S. aureus in the presence or absence of bacteriostatic/bactericidal and bacteriolytic 247 
antibiotics. The antibiotics tested could limit or prevent a rise in α-toxin levels, however there were differences 248 
in their time courses of action. The bacteriostatic/bactericidal agent, linezolid, appeared more rapid and potent 249 
than the bacteriolytic antibiotic, penicillin. There was, however, no evidence of a detectable ‘pulse’ of α-toxin–250 
induced haemolysis following addition of any of the antibiotics studied, suggesting there was no substantial 251 
intracellular ‘pool’ of stored α-toxin in the S. aureus strain DU5946.  In the bovine cartilage model of septic 252 
arthritis, S. aureus cultures rapidly caused chondrocyte death. However chondrocytes were completely 253 
protected against S. aureus by the antibiotics tested (linezolid, flucloxacillin, penicillin, erythromycin). These 254 
results were important for elucidating whether or not there was a significant intracellular store of α-toxin as 255 
this may be relevant for antibiotic selection during S. aureus-induced septic arthritis. 256 
The rabbit RBC haemolysis bio-assay was used to determine the time course of α-toxin release during 257 
S. aureus culture. The measurement of haemoglobin released following the interaction between α-toxin and 258 
erythrocytes provided a dynamic and sensitive assay for the lethal effects of α-toxin, and was highly flexible 259 
experimentally and reproducible, allowing several conditions (e.g. drug concentrations) to be tested at the same 260 
time points. The other toxins/damaging agents produced by S. aureus had a negligible effect on rabbit 261 
erythrocytes emphasising the specific nature of this assay for α-toxin (Fig. 1). It was noted that some blood 262 
samples were very sensitive to α-toxin whereas others were relatively unresponsive and so it was necessary to 263 
initially screen each blood sample for sensitivity against a S. aureus culture. Once a blood sample was deemed 264 
acceptable, the time course of haemolysis to α-toxin was highly reproducible. In addition, the ability of S. 265 
aureus cultures to produce sufficient quantities of potent α-toxin was variable and probably depended on 266 
prevailing culture conditions. The difference in potency of batches of α-toxin was observed, as for example, 267 
in one series of experiments, 60mins elapsed before the S. aureus culture started to produce measurable α-268 
toxin levels (Fig. 2(a)). In another set of experiments performed with a different α-toxin preparation, after only 269 
40mins haemolysis had already increased to 20% (Fig. 4(a)). The rabbit erythrocyte model for determining the 270 
effects of antibacterials on α-toxin levels might be considered a limitation. However, rabbit erythrocytes 271 
contain the S. aureus α-toxin receptor ADAM-10 also present on chondrocytes of animals and normal and 272 
degenerate human cartilage16-18. Our previous work has demonstrated that in a cartilage model of septic 273 
arthritis, α-toxin is the key damaging agent to chondrocytes and thus the rabbit erythrocyte hemolysis assay is 274 
appropriate to determine the effects of antibacterials on α-toxin release from S. aureus cultures14,15.  275 
Linezolid at 25 or 50µg/ml rapidly abolished the rise in α-toxin–induced haemolysis (Fig. 2(c)) 276 
probably because of its potent action on bacterial protein synthesis and replication31. However, linezolid may 277 
have both bacteriostatic and/or bactericidal effects on S. aureus depending on concentration and experimental 278 
conditions22. Therefore the reduced rate of haemolysis in linezolid-treated cultures may be the result of 279 
bacteriostatic, bactericidal or combined bacteriostatic/bactericidal action. Whatever the mechanism, at 280 
50µg/ml linezolid (Fig. 3(a,b)), there was no progressive change in haemolysis ((Fig. 2(c); Fig. 3(b)) indicating 281 
no additional release of α-toxin from dying/dead bacteria. However, future work would be required to 282 
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investigate the effect of varying concentrations of linezolid on the bacteriostatic and/or bactericidal modes of 283 
actions on S. aureus α-toxin. It should be noted that to test our hypothesis of whether there was a detectable 284 
intracellular store of α-toxin, we used concentrations considerably above the MIC (minimum inhibitory 285 
concentrations;Table 2) and have not atttempted to study the effects of clinically-relevant doses.  286 
The action of penicillin was slower compared to linezolid as evidenced by the relatively tardy 287 
inhibition of α-toxin-induced haemolysis even at a high concentration (50,000U/ml;Fig. 4(c);Fig. 5(a,b)). 288 
There are two possible explanation for this finding. The most likely interpretation of these results is because 289 
of the slower time course of the antibiotic inhibiting bacterial cell wall synthesis21,22. The level of haemolysis 290 
after penicillin addition was higher than that with linezolid, and did not change with time (Fig. 6). This 291 
suggested that the inhibition by both drugs was maximal with no further bacterial death or inhibition of 292 
division. However it is also possible that the slightly elevated level of haemolysis (~8% of the total) with a 293 
high dose of penicillin (Fig. 6) could have been because of the release of the small additional amount of 294 
intracellular α-toxin from the dying/dead bacteria.  295 
The presence of a small amount of intracellular S. aureus α-toxin is implied by others using different 296 
methods to cause bacterial damage. For example Duncan and Cho32 suggested that mechanical disruption of 297 
S. aureus released 1-2% of total toxin present in cultures. However this might have been influenced by the 298 
simultaneous release of degradative enzymes leading to an underestimation in the amount of active toxin. 299 
Monecke et al33 using alkali treatment, noted that there was only a ‘small’ (but unquantified) level of stored α-300 
toxin following bacterial lysis. For S. aureus therefore, there might only be a small intracellular store with the 301 
α-toxin released rapidly after synthesis. On the other hand, pneumolysin, the toxin produced by Streptococcus 302 
pneumoniae, is almost exclusively stored intra-cellularly and only released through bacterial autolysis34,35. In 303 
a S. pneumoniae rabbit meningitis model, addition of the bacteriolytic agent ceftriaxone, released substantial 304 
additional quantities of pneumolysin compared to the non-bacteriolytic agent rifampin, with the additional 305 
toxin causing further cellular damage and inflammation36.  306 
In the S. aureus septic arthritis cartilage model, linezolid and penicillin (Fig. 7a,b) and flucloxacillin 307 
and erythromycin (see Results) were equally effective This might appear to conflict with the suggestion above 308 
that there was a small intracellular ‘pool’ of α-toxin. It is possible that the methods for determining chondrocyte 309 
death were not sufficiently sensitive to detect the small increase from the release of stored α-toxin by penicillin. 310 
However there was no significant difference in % chondrocyte viability between linezolid and penicillin-311 
treated explants so this does not seem likely. Alternatively, α-toxin levels in the medium and thus the cartilage 312 
matrix may already be high and any small increase following penicillin treatment could be without further 313 
detectable effect. The α-toxin released from S. aureus will have a rapid effect on the rabbit erythrocytes as 314 
pore formation and haemolysis proceeds promptly19. However in cartilage, toxin permeability may be hindered 315 
by the cartilage extracellular matrix37. It is also possible that the dynamics of toxin binding and pore formation 316 
to bovine chondrocytes proceeds with a different time course compared to rabbit erythrocytes. ADAM-10 (A 317 
Disintegrin And Metalloproteinase domain-containing protein-10) has been identified as an important receptor 318 
for α-toxin binding38  mediating changes to intracellular Ca2+ signalling39 and is present on human chondrocytes 319 
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and up-regulated in osteoarthritis16-18. The binding site density on chondrocytes may also be different compared 320 
to rabbit erythrocytes which could further influence the time course of the α-toxin effect.  321 
The rapid inhibition by linezolid on the rise in S. aureus α-toxin levels compared to penicillin is likely 322 
due to a bacteriostatic action on S. aureus replication, and in vivo this would be followed by bacteria removal 323 
by the immune system. Septic arthritis may be regarded as a medical emergency3 and thus clinically there 324 
would be benefit in administering this antibacterial agent or others in this class for the most rapid action 325 
possible to protect joint tissues from further damage.  It is possible that bacteriolytic antibiotics (e.g. penicillin, 326 
flucloxacillin) may lead to the release of additional inflammatory components (e.g. teichoic acids, 327 
peptidoglycans) from S. aureus potentially causing further chondrocyte damage.  However all the drugs tested 328 
(penicillin, linezolid (Fig. 7); flucloxacillin, erythromycin (see Results)), were equally effective at protecting 329 
chondrocytes against S. aureus. This suggests that these agents, if released from dead/dying bacteria, do not 330 
have a significant effect on chondrocyte viability and support the view that the α-toxin alone was the primary 331 
cause of chondrocyte death15. It is also worth noting that bacteriostatic/bactericidal agents e.g. linezolid, reduce 332 
the expression of S. aureus α-toxin29,31. This is in marked contrast to sub-inhibitory doses of β-lactams which 333 
increase S. aureus hla (α-toxin) mRNA expression40,41 and therefore might cause concern in the treatment of 334 
osteoarticular infection by these bacteria. Furthermore, linezolid reduces expression of other staphylococcal 335 
toxins such as PVL in PVL-associated staphylococcal pneumonia42. Since PVL-producing strains of S. aureus 336 
may also be present and can cause complications in septic arthritis43, linezolid may offer a further advantage 337 
over bacteriolytic antibiotics. Although our results demonstrated that these antibacterials are protective against 338 
chondrocytes in vitro, the response in vivo is likely to be far more complex as our model of S. aureus-induced 339 
septic arthritis does not include the host’s immune response.  340 
While it can be particularly challenging to extrapolate the results from the in vitro situation to the 341 
clinical setting, there are three main findings from this study which are relevant. (a) The time course of the 342 
bacteriostatic/bactericidal antibiotic linezolid on limiting the rise α-toxin was clearly more rapid than for the 343 
bacteriolytic antibiotic penicillin (Fig. 2 vs Fig. 4). (b) There was a negligible amount of stored α-toxin released 344 
following antibacterial treatment (Fig. 6).  (c) There was no significant difference in the chondroprotective 345 
effect between exemplars of the two classes of antimicrobials in the septic arthritis model (Fig. 7). It is also 346 
relevant to note that Monecke et al.33 have presented evidence to indicate that secretion of S. aureus α-toxin 347 
does not appear to correlate with the progression of septic arthritis.  There is nevertheless a strong link between 348 
levels of α-toxin and chondrocyte death14,15 and it is known that cartilage which does not possess viable 349 
chondrocytes will degenerate44. Thus, while there is probably a relationship between levels of α-toxin in S. 350 
aureus – induced septic arthritis and in vivo cartilage viability, a direct correlation is yet to be established. 351 
Despite this, the dominant importance of α-toxin produced by S. aureus in septic arthritis as opposed to other 352 
damaging agents released by this bacterium, has been underscored by recent preliminary in vivo studies45. In 353 
these experiments, the intra-articular injection of S. aureus 8325-4 which produces all toxins including α-toxin 354 
and other damaging agents, was compared to the injection of an S. aureus mutant (DU1090) which produces 355 
the full range of toxins/enzymes, except α-toxin15. Mice injected with either S. aureus strains developed septic 356 
arthritis with evidence of weight loss, limb swelling and gait changes whereas these were absent in the control 357 
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(PBS – injected) group. Notably, there was significantly (P<0.05) more chondrocyte death in the group infected 358 
with S. aureus 8325-4 (approx. 93% chondrocyte death) when compared to DU1090 (approx. 26% chondrocyte 359 
death) and PBS-injected (i.e. control) mice (5% chondrocyte death). The results suggested that α-toxin was the 360 
major chondrocyte damaging agent, but also any adverse effect of the immune system during this time course 361 
with this animal model of septic arthritis was negligible in comparison. While antimicrobial treatment of S. 362 
aureus to limit further production of α-toxin is clearly an essential clinical approach, strategies aimed at quickly 363 
suppressing the action of α-toxin already present in the infected tissue could be of additional benefit. For 364 
example, the damaging effect of α-toxin is markedly suppressed by raising the osmolarity of the culture 365 
medium20.  366 
This present study utilised a rabbit RBC assay to determine α-toxin levels produced by S. aureus in 367 
culture following treatment with antibiotics. Linezolid rapidly limited any further increase in α-toxin levels by 368 
S. aureus whilst penicillin had a slower time course of action. There was a small additional release of α-toxin 369 
following penicillin addition suggesting a delayed action and/or a small intracellular store of α-toxin. However, 370 
both drugs were equally effective at protecting chondrocytes in our S. aureus septic arthritis model. 371 
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Tables 539 
 540 
 541 
Table 1. Miller et al., (2018)  542 
 543 
 544 
S. aureus 
strain 
Genotype Phenotype Haemolysins 
produced 
Given name 
DU5946 Hlb::ɸ42E Δhlg::Tcr Hla+ Hlb- Hlg- Hla α-toxin positive 
α+ β- γ- 
DU5938 Hlb::ɸ42E hla::Emr  
Δhlg::Tcr 
Hla- Hlb- Hlg- None α-toxin deficient 
α- β- γ- 
 545 
Table 1.  The bacterial strains used in study.  The strain of S. aureus is shown with its genotype, 546 
phenotype and the toxins produced.  Tc r = Tetracycline resistance.  Em r = Erythromycin resistance. 547 
  548 
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Table 2. Miller et al., (2018)  549 
 550 
  Antibiotic Dose 
Antibiotic Class 
(action) 
Mode of action 
(on bacteria) 
Dose used MIC Reference 
Linezolid Oxazolidinone 
(bacteriostatic/ 
bactericidal) 
Ribosomal 50S 
inhibitor – 
interrupts protein 
synthesis  
50μg/ml for 
haemolysis 
experiments; 
25μg/ml for 
cartilage 
experiments. 
0.12-8μg/ml 
 
46 
Erythromycin Macrolide 
(bacteriostatic/ 
bactericidal) 
Ribosomal 50S 
inhibitor – 
interrupts protein 
synthesis 
10μg/ml for 
cartilage 
experiments. 
0.06-128μg/ml 46 
      
Penicillin -lactam 
(bacteriolytic) 
Blocks cross-
linking of 
peptidoglycan - 
inhibits cell wall 
formation 
50,000U/ml 
(34mg/ml) for 
haemolysis 
experiments; 
1000U/ml 
(0.70μg/ml) for 
cartilage 
experiments.  
0.015-128μg/ml 46 
Flucloxacillin -lactam 
(bacteriolytic) 
Blocks cross-
linking of 
peptidoglycan - 
inhibits cell wall 
formation 
2mg/ml  
for cartilage 
experiments. 
0.4μg/ml  
(fully effective) 
21 
 551 
Table 2.  Antibiotics and concentrations used in study.  The class, mode of action and concentration of 552 
antibiotics used are shown. The MIC (minimum inhibitory concentration) for linezolid against S. aureus ranges 553 
over 0.12-8μg/ml46,47; and the MIC90 (minimum inhibitory concentration required to block 90% bacterial 554 
growth) ranges over 2-4μg/ml48. Doses used in the present work ranged from 5-50μg/ml and were effective 555 
(Fig. 2(c), Fig. 7a)). The MIC for erythromycin on Staphlococci ranges over 0.06-128μg/ml46 and the dose 556 
used for cartilage experiments was 10μg/ml. The MIC for penicillin action on Staphlococci ranges over 0.015-557 
128μg/ml46. The present study used 50,000U/ml (34mg/ml) for haemolysis experiments and 1000U/ml 558 
(0.70μg/ml) for cartilage experiments which were effective (Figs. 4(c) and 7); see text).  Flucloxacillin has 559 
been shown to be completely effective against S. aureus when present at 0.4μg/ml21. In the present study a 560 
concentration of 2mg/ml was used (see text). 561 
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 562 
Figure Legends 563 
 564 
Figure 1. The haemolysis of rabbit erythrocytes following incubation with -toxin positive or -toxin 565 
negative strains of S. aureus. (a) Cultures of S. aureus (i) α-toxin positive, β and γ-toxin negative strain or 566 
(ii) α-toxin negative, β and γ-toxin negative strain (DU5938; Table 1) were incubated on tryptone soya agar 567 
(TSA) containing rabbit erythrocytes. Clear areas surrounding colonies of -toxin secreting S. aureus represent 568 
the haemolysis of rabbit erythrocytes. No haemolysis was observed around colonies of the -toxin negative 569 
strain. (b) The time course of haemolysis in suspensions of rabbit erythrocytes during culture with α-toxin 570 
positive or α-toxin negative strain of S. aureus. For this and subsequent Figures, when error bars were not 571 
shown they were smaller than the symbols. Data shown are means ± s.e.m. for 3 independent experiments for 572 
each condition.  573 
 574 
Figure 2. Effects of linezolid on -toxin-induced haemolysis of rabbit erythrocytes. Panel (a) shows the 575 
effect of linezolid (0 (HBSS control), 5, 10, 25 or 50μg/ml) addition at 80mins to S. aureus α-toxin positive 576 
strain (DU5946) cultures on -toxin-induced haemolysis (see Materials and Methods for details). Panel (b) 577 
presents the rate of change of haemolysis over 100-140mins ((expressed as the % change/min) x10) extent 578 
following addition of linezolid with increasing concentration. Asterisks (* or **) represent significant 579 
differences at the P<0.05 or P<0.001 levels respectively.  Panel (c) demonstrates the effects of linezolid 580 
(50μg/ml) addition to S. aureus cultures at 60, 80, 100 and 130mins corresponding to approximately 0, 10, 40 581 
or 80% -toxin-induced haemolysis. Data shown are means ± s.e.m. for at least 3 independent experiments.  582 
 583 
Figure 3. Inhibition of -toxin-induced haemolysis of rabbit erythrocytes at different time points by 584 
prior treatment with linezolid. Linezolid (50μg/ml) was added (a) 60mins or (b) 100mins after the initiation 585 
of S. aureus α-toxin positive strain (DU5946) cultures which corresponded to approximately 0 or 40% -toxin-586 
induced haemolysis respectively at the start of the experiment. Measurements of %H were then taken at 0, 40 587 
and 60mins as shown. At 40 and 60mins, the prior treatment with linezolid significantly (P<0.001) reduced -588 
toxin-induced haemolysis to levels that were not significantly different from the control (i.e. levels of %H at 589 
the start of the time course). Data shown are means ± s.e.m. for at least 3 independent experiments. 590 
 591 
Figure 4. Effects of penicillin on -toxin-induced haemolysis of rabbit erythrocytes. Panel (a) shows the 592 
effect of penicillin (0, 5,000, 10,000, 25,000 or 50,000U/ml) addition at 60mins to α-toxin positive strain 593 
(DU5946) S. aureus cultures on -toxin-induced haemolysis (see Materials and Methods for details). Panel 594 
(b) presents the extent of -toxin-induced haemolysis at 140mins following addition of penicillin. The 595 
inhibition by penicillin was only significantly different from the HBSS control at 50,000 and 250,000U/ml 596 
(P<0.001) whereas there was no significant difference between these two antibiotic concentrations. Panel (c) 597 
demonstrates the effects of penicillin (50,000 U/ml) addition to S. aureus cultures at 20, 40, 60 and 100 mins 598 
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corresponding to approximately 0, 10, 40 or 80% -toxin-induced haemolysis. Data shown are means ± s.e.m. 599 
for at least 3 independent experiments.  600 
 601 
Figure 5. Inhibition of -toxin-induced haemolysis of rabbit erythrocytes at different time points by 602 
prior treatment with penicillin. Penicillin (50,000U/ml) was added (a) 20mins or (b) 60mins after the 603 
initiation of α-toxin positive strain (DU5946) S. aureus cultures which corresponded to approximately 0 or 604 
60% -toxin-induced haemolysis at the start of the experiment. Measurements of %H were then taken at 0, 40 605 
and 60mins as shown. At 40 and 60mins, the prior treatment with penicillin significantly (P<0.001) reduced 606 
-toxin-induced haemolysis. For the penicillin-treated cultures, there were small but significant (P<0.05) 607 
increases in %H for (a) at 40 and 60mins, and for (b) at 60mins compared to the %H values at 0mins. Data 608 
shown are means ± s.e.m. for at least 3 independent experiments. 609 
 610 
Figure 6. Comparison between the inhibitory effects of penicillin and linezolid on the extent of -toxin-611 
induced haemolysis. A single dose of penicillin (250,000U/ml) or linezolid (25μg/ml; final concentrations) 612 
was added to α-toxin positive strain (DU5946) S. aureus cultures after 60mins (corresponding to approximately 613 
55% haemolysis) and -toxin-induced haemolysis determined. There was a significant reduction in levels of 614 
-toxin-induced haemolysis for both drugs at 20, 40, 60 and 80mins compared to the untreated control at the 615 
same time points. However the inhibition was significantly greater for the linezolid-treated cultures compared 616 
to those following penicillin addition at 40, 60 and 80mins (P<0.01). Data shown are means ± s.e.m. for 3 at 617 
least independent experiments. 618 
 619 
 620 
Figure 7. Protection of in situ chondrocytes by penicillin or linezolid against S. aureus infection in a 621 
bovine model of septic arthritis.  Bovine cartilage was incubated with α-toxin positive strain (DU5946) S. 622 
aureus cultures for 15hrs, which produced approximately 20% chondrocyte death (infected), or in the absence 623 
of bacteria (uninfected). Cultures were then continued untreated, or following the addition (at the arrow) of 624 
penicillin (1,000U/ml) or linezolid (25μg/ml). Data shown are means ± s.e.m. for 6 independent experiments. 625 
Examples of confocal images of chondrocytes in bovine cartilage taken after 23hrs are shown for the following 626 
conditions (a) uninfected (<2% cell death), (b) infected penicillin – treated (about 20% cell death), (c) infected 627 
linezolid – treated (~21% cell death) and (d) infected untreated  (~100% cell death). The scale bar is 100μm 628 
for all panels.  629 
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